These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11231971)

  • 1. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.
    Santen RJ; Pinkerton J; McCartney C; Petroni GR
    J Clin Endocrinol Metab; 2001 Jan; 86(1):16-23. PubMed ID: 11231971
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Garton M
    Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
    [No Abstract]   [Full Text] [Related]  

  • 3. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Magnusson C; Persson I; Adami HO
    J Natl Cancer Inst; 2000 Jul; 92(14):1183-4. PubMed ID: 10904095
    [No Abstract]   [Full Text] [Related]  

  • 6. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HRT debate (hormone replacement therapy in menopause)].
    Lesur A; Saint-Léger S
    Bull Cancer; 2000 Jul; 87(7-8):522-4. PubMed ID: 10969204
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Shapiro S
    Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
    [No Abstract]   [Full Text] [Related]  

  • 9. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
    Campagnoli C; Clavel-Chapelon F; Kaaks R; Peris C; Berrino F
    J Steroid Biochem Mol Biol; 2005 Jul; 96(2):95-108. PubMed ID: 15908197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Helmond FA
    Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575988
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Bundred NJ; Morris J
    Lancet; 2003 Oct; 362(9392):1329; author reply 1330-1. PubMed ID: 14575987
    [No Abstract]   [Full Text] [Related]  

  • 12. HRT 2000: pause for thought.
    Harv Womens Health Watch; 2000 Apr; 7(8):1-3. PubMed ID: 10712769
    [No Abstract]   [Full Text] [Related]  

  • 13. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 14. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
    Gadducci A; Biglia N; Cosio S; Sismondi P; Genazzani AR
    Gynecol Endocrinol; 2009 Dec; 25(12):807-15. PubMed ID: 19906000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-progestin replacement therapy: regulatory action needed.
    Pike MC; Ross RK
    Breast Cancer Res; 2002; 4(6):222-3. PubMed ID: 12473167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy, progesterone and progestins in relation to breast cancer risk.
    Campagnoli C; Abbà C; Ambroggio S; Peris C
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):441-50. PubMed ID: 16249080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.
    Persson I; Weiderpass E; Bergkvist L; Bergström R; Schairer C
    Cancer Causes Control; 1999 Aug; 10(4):253-60. PubMed ID: 10482483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X; Seeger H; Mueck AO
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Committee opinion: number 262, December 2001. Risk of breast cancer with estrogen-progestin replacement therapy.
    ACOG Committee on Gynelogical Practice
    Obstet Gynecol; 2001 Dec; 98(6):1181-4. PubMed ID: 11755583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR
    Cancer; 2003 Oct; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.